Actively Recruiting
A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
Led by Ruijin Hospital · Updated on 2025-03-14
10
Participants Needed
1
Research Sites
155 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a single-center, parallel-controlled clinical study designed to evaluate the safety, efficacy and impact on systemic anti-tumor immunity of a multi-mode integrated ablation system for the treatment of breast cancer liver metastases.
CONDITIONS
Official Title
A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female aged 18 to 75 years
- Pathologically confirmed breast cancer liver metastases in patients unable to tolerate or refusing surgery
- Three or fewer liver lesions, each with a diameter of 4 cm or less
- At least 1 month since the last local treatment
- Child-Pugh class A or B liver function
- ECOG performance status score of 2 or less with expected survival over 3 months
You will not qualify if you...
- Liver function Child-Pugh class C
- Systemic widespread metastasis with expected survival less than 3 months
- History of esophageal or gastric fundus variceal bleeding within the past month
- Dysfunction or failure of vital organs
- Presence of active infection
- Irreparable coagulation abnormalities
- Refractory massive ascites, pleural effusion, or cachexia
- Pregnancy, altered consciousness, or inability to cooperate with treatment
- Participation in other clinical studies with ongoing follow-up
- Any other condition deemed inappropriate for study participation by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, China
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here